Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05108220 · ClinicalTrials.gov registry record
Evaluation of Effects of CBD Products on Anxiety Among U.S. Women
A clinical trial, sponsored by Radicle Science.
- Completed
- Registry status
- 1,350
- Enrollment target
NCT05108220 is a clinical trial that has completed, run by Radicle Science. The registered enrollment target is 1,350 participants.
The verdict
NCT05108220 has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- 1,350 participants
- Enrollment target
Study Summary
The investigators will conduct a retrospective cohort analysis of a consumer trial conducted by Rae Wellness. The trial took place between October 15, 2020 and December 30, 2020 and involved 1350 U.S. women who used in-home use tests (IHUT) of various Cannabidiol (CBD) products. Participants were randomized to one of 9 groups: 8 groups received one of 8 different CBD products in the mail, and one group served as the control and did not consume any CBD product. The CBD products varied by method of delivery, concentration of Tetrahydrocannabinol (THC), and dosage of CBD. Participants were asked to use the product once daily for 60 day and to complete health questionnaires at baseline, 30 days and 60 days.
Interventions
- DIETARY_SUPPLEMENT Cannabidiol (CBD)- containing consumer products
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,350 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2020-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05108220
The ClinicalTrials.gov registry entry for NCT05108220 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radicle Science, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabidiol (CBD)- containing consumer products is the first listed.
NCT05108220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05108220 about?
NCT05108220 is a clinical study titled "Evaluation of Effects of CBD Products on Anxiety Among U.S. Women". The investigators will conduct a retrospective cohort analysis of a consumer trial conducted by Rae Wellness. The trial took place between October 15, 2020 and December 30, 2020 and involved 1350 U.S. women who used in-home use tests (IHUT) of various Cannabidiol (CBD) products. Participants were ra...
What is the current status of trial NCT05108220?
This trial is currently completed. The enrollment target is 1,350 participants. The study started on 2020-10-15. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT05108220?
The interventions under investigation include: Cannabidiol (CBD)- containing consumer products (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05108220?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.